Form 4: New Enterprise Associates 16, L.P. Acquires Shares in Marker Therapeutics, Inc.

New Enterprise Associates 16, L.P. acquired 554,250 shares of Marker Therapeutics, Inc. at $3.20 per share on December 23, 2024, increasing its holdings to 1,625,678 shares.

Summary

• On December 23, 2024, New Enterprise Associates 16, L.P. (NEA 16) purchased 554,250 shares of Marker Therapeutics, Inc. common stock.
• The purchase price was $3.20 per share.
• Following the transaction, NEA 16 directly holds 1,625,678 shares of Marker Therapeutics, Inc.
• The transaction was made pursuant to a Securities Purchase Agreement dated December 19, 2024.
• The reported securities amounts have been adjusted to reflect a 1-for-10 reverse stock split that occurred on January 26, 2023.
• The filing also includes a power of attorney, granting Zachary Bambach, Nicole Hatcher, and Stephanie Brecher the authority to act on behalf of several individuals related to NEA for SEC filings.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing detailing a transaction. The increased holding could be seen as a positive signal, but without further context, it's difficult to gauge the overall sentiment.

Positives

• NEA 16's increased investment in Marker Therapeutics could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders and major shareholders. This filing indicates the investment activity of a significant shareholder in Marker Therapeutics.

Stakeholder Impact

• The increased stake by NEA 16 could positively influence shareholder confidence.

Key Dates